These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1620357)

  • 1. Report of the MDA Gene Therapy Conference, Tucson, Arizona, September 27-28, 1991.
    Rossiter BJ; Stirpe NS; Caskey CT
    Neurology; 1992 Jul; 42(7):1413-8. PubMed ID: 1620357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for muscular dystrophies: current status and future prospects.
    Takeda S; Miyagoe-Suzuki Y
    BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.
    Kumar-Singh R; Chamberlain JS
    Hum Mol Genet; 1996 Jul; 5(7):913-21. PubMed ID: 8817325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.
    Cho WK; Ebihara S; Nalbantoglu J; Gilbert R; Massie B; Holland P; Karpati G; Petrof BJ
    Hum Gene Ther; 2000 Mar; 11(5):701-14. PubMed ID: 10757350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T; Popplewell L; Athanasopoulos T; Dickson G
    Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy prospects for Duchenne muscular dystrophy.
    Clemens PR; Caskey CT
    Eur Neurol; 1994; 34(4):181-5. PubMed ID: 8082675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.
    Karpati G; Acsadi G
    Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DMD gene promoter: a potential role in gene therapy.
    Ray PN; Klamut HJ; Worton RG
    Adv Exp Med Biol; 1990; 280():107-11; discussion 111-2. PubMed ID: 2248131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
    Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoblast transfer and gene therapy in muscular dystrophies.
    Pagel CN; Morgan JE
    Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
    Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
    Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in genome editing technologies for treating muscular dystrophy.].
    Makita Y; Hozumi H; Hotta A
    Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dystrophin Complex: Structure, Function, and Implications for Therapy.
    Gao QQ; McNally EM
    Compr Physiol; 2015 Jul; 5(3):1223-39. PubMed ID: 26140716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo.
    Dunckley MG; Wells DJ; Walsh FS; Dickson G
    Hum Mol Genet; 1993 Jun; 2(6):717-23. PubMed ID: 8353491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene.
    Vincent N; Ragot T; Gilgenkrantz H; Couton D; Chafey P; Grégoire A; Briand P; Kaplan JC; Kahn A; Perricaudet M
    Nat Genet; 1993 Oct; 5(2):130-4. PubMed ID: 8252038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability.
    Decrouy A; Renaud JM; Davis HL; Lunde JA; Dickson G; Jasmin BJ
    Gene Ther; 1997 May; 4(5):401-8. PubMed ID: 9274716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.